Haoxi Health Technology Ltd (HAO) Actualités

Haoxi Health Technology Limited Announces 1-for-25 Reverse Share Split

BEIJING, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Haoxi Health Technology Limited Awarded a RMB30 Milllion Framework Contract to Provide Digital Advertising Services for Tengyuan Media Advertising Co., Ltd.

BEIJING, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Haoxi Health Technology Limited Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

BEIJING, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an...

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Haoxi Health Technology Limited Reports Financial Results for Fiscal Year Ended June 30, 2024

BEIJING, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Haoxi Health Technology Limited and Global Mofy AI Ltd Announce Strategic Partnership to Innovate AI Marketing Solutions

BEIJING, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Haoxi Health Technology Limited Announces the Closing of a $12 Million Underwritten Follow-on Public Offering

BEIJING, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an...

Form 424B4 - Prospectus [Rule 424(b)(4)]

Form EFFECT - Notice of Effectiveness